NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from Shanghai Wibson Biotechnology WBS? Mail in a sample (US only) and let us test it.

Test my supply
+12 more ↓
65%
Finnrick rating
#375 of 500 ranked vendors
51 of 71 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Shanghai Wibson Biotechnology WBS shows its strongest purity-focus evidence in Tirzepatide and GHK-Cu, while Retatrutide has recent recovery but remains volatile. Weakness is concentrated in Cagrilintide, TB-500, and Ipamorelin; results are dispersed, recent, and higher-volume overall, with uneven batch details.

methodology →
vendor intelligence report
Vendor Intelligence Report: Shanghai Wibson Biotechnology WBS

Corporate records, rep posts, and WHOIS trails do not reconcile around WBS’s official seller or legal counterparty. The full brief maps copied lab identities, lookalike Janoshik verification routes, parasite-SEO funnels, and shared storefront code.

36 pages8 risk factors assessed12 Nov 2026
read the report
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%12 Jun 2026: 62%16 Jun 2026: 63%16 Jun 2026: 64%17 Jun 2026: 64%1 Jul 2026: 64%1 Jul 2026: 64%1 Jul 2026: 64%13 Jul 2026: 64%13 Jul 2026: 64%13 Jul 2026: 64%14 Jul 2026: 64%17 Jul 2026: 65%17 Jul 2026: 65%20 Jul 2026: 65%21 Jul 2026: 65%23 Jul 2026: 65%23 Jul 2026: 65%4 Aug 2026: 65%4 Aug 2026: 66%4 Aug 2026: 66%4 Aug 2026: 66%12 Aug 2026: 65%26 Aug 2026: 66%8 Sep 2026: 66%15 Sep 2026: 65%15 Sep 2026: 65%17 Sep 2026: 64%18 Sep 2026: 65%24 Sep 2026: 65%25 Sep 2026: 65%6 Oct 2026: 65%16 Oct 2026: 66%20 Oct 2026: 65%27 Oct 2026: 65%27 Oct 2026: 66%29 Oct 2026: 66%2 Nov 2026: 65%2 Nov 2026: 65%2 Nov 2026: 65%2 Nov 2026: 65%17 Nov 2026: current 65%62%66%65%Jun 26Nov 26
Peptide testing

Ordered peptides from Shanghai Wibson Biotechnology WBS? Mail in a sample (US only) and let us test it.

Test my supply
Shanghai Wibson Biotechnology WBS test history
COA-backed lab tests
1-10 of 72

About Shanghai Wibson Biotechnology WBS test results from Finnrick

Shanghai Wibson Biotechnology WBS is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 8 peptides and 72 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Shanghai Wibson Biotechnology WBS peptides in this dataset are BPC-157 (6 tests), Cagrilintide (4 tests) and GHK-Cu (5 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 72 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from Shanghai Wibson Biotechnology WBS? Mail in a sample (US only) and let us test it.

Test my supply